This is because these alterations never occur alongside amplification of the MYCN gene, which affects about 35 percent of high-risk patients. It is not yet known whether neuroblastoma with ATRX ...

We focus on the role of the MYCN oncogene, since aberrant expression of MYCNis very significantly associated with high-risk in all three diseases and implies that they may have a common cell-of-origin ...